Back to Search
DAVID QUINN, M.D.
M.D.
Gastroenterology Physician
NPI: 1538187240IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
057648(GA)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
PMID 12673714·Cancer·2003
8-other
Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.
PMID 11504751·J Clin Oncol·2001
8-other
Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
PMID 10749127·Cancer Res·2000
8-other
Inhibition of HA synthase 3 mRNA expression, with a phosphodiesterase 3 inhibitor, blocks lung injury in a septic ventilated rat model.
PMID 19572173·Lung·2009
7-preclinical
The health care matrix formulation: a tool for competency assessment in psychiatry residency training.
PMID 19593287·South Med J·2009
5-case
Perioperative chemotherapy for urothelial cancer: how have we made a "sow's ear" out of a chemotherapy-sensitive tumor?
PMID 19645028·Cancer·2009
8-other
Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.
PMID 19580651·Crit Care·2009
7-preclinical
Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.
PMID 19020886·World J Urol·2009
8-other
The role of phosphodiesterase 3 in endotoxin-induced acute kidney injury.
PMID 19486524·BMC Infect Dis·2009
7-preclinical
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.
PMID 19396016·Anticancer Drugs·2009
3-trial
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma.
PMID 19385713·Clin Pharmacokinet·2009
4-observational
Using the healthcare matrix with interns and medical students as a tool to effect change.
PMID 19593275·South Med J·2009
8-other
The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial.
PMID 19324916·Eur Heart J·2009
4-observational
Acetylation of sox2 induces its nuclear export in embryonic stem cells.
PMID 19591226·Stem Cells·2009
7-preclinical
Complications of carbon monoxide poisoning: a case discussion and review of the literature.
PMID 19617936·Prim Care Companion J Clin Psychiatry·2009
8-other
Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
PMID 19213668·Clin Genitourin Cancer·2009
3-trial
USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.
PMID 19188362·J Biol Chem·2009
7-preclinical
An evaluation of the completeness of reporting of childhood tuberculosis.
PMID 19251788·Eur Respir J·2009
8-other
Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.
PMID 19287558·Prim Care Companion J Clin Psychiatry·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1800 HOWELL MILL RD NW STE 600
ATLANTA, GA 30318 - Phone
- (404) 351-9512
Quick Facts
- NPI
- 1538187240
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile